Carregant...
ACTR-52. CLINICAL IMPACT OF TERT PROMOTER DETECTION IN CIRCULATING CELL-FREE DNA OF PATIENTS WITH GLIOBLASTOMA – A PILOT STUDY
BACKGROUND: Detection of circulating cell-free tumor-derived DNA (cfDNA) has been shown to be of clinical value in monitoring cancer treatment. Having in mind that somatic TERT promoter (TERTp) mutations are clonal and frequent in IDH-wild-type glioblastoma (GBM), we conducted a pilot study to asses...
Guardat en:
| Publicat a: | Neuro Oncol |
|---|---|
| Autors principals: | , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Oxford University Press
2017
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5692736/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox168.043 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|